ACT Price Prediction Next Week
Analysis and Insights
Technical Analysis:
The stock price of ACT.O is currently trading at 34.45 as of 2025-03-24. Based on the technical indicators:
- RSI (14): 51.94, indicating a neutral position, not overbought or oversold.
- MACD: 0.04, showing a slight bullish momentum.
- Stochastic Oscillator: %K (63.70) is above %D (57.57), suggesting a bullish signal.
- Fibonacci Levels: The stock is currently near the R1 level (34.11) and could test the R2 level (34.54) if the bullish momentum continues.
News Sentiment:
- The recent news does not directly impact ACT.O but suggests broader market dynamics. For example, the lawsuit involving the White House and AP, as well as Musk's comments on immigration policies, could influence market sentiment but do not directly affect ACT.O's fundamentals.
Price Prediction:
Based on the technical indicators and the current price action, ACT.O is expected to reach $34.54 in the next trading week. The stock is likely to break above the R1 level (34.11) and test the R2 level (34.54) if the bullish momentum continues.
Recommendation:
Buy ACT.O at the current price of 34.45, with a target price of 34.54. The bullish technical indicators and the proximity to the Fibonacci R1 level suggest a potential upside in the short term.
ACT Similar Chart Price Prediction
The price of ACT is predicted to go up -13.58%, based on the high correlation periods with HZO. The similarity of these two price pattern on the periods is 90.2%.
ACT
HZO
Down: -13.58%Similarity: 90.2%
ACT Revenue Forecast
ACT EPS Forecast
ACT FAQs
What is ACT revenue forecast for next quarter？
What is ACT eps forecast for next quarter？
ACT Analyst's Forecast
Richard Shane
JP Morgan
Hold
2024-12-09
Price Target
$39 → $36
Upside
+5.96%
JPMorgan lowered the firm's price target on Enact Holdings to $36 from $39 and keeps a Neutral rating on the shares. The firm says market outcomes for consumer and specialty finance in 2025 will likely be determined by how far the Trump administration can go in implementing its policy objectives. The stocks already appear to be incorporating many of the more likely outcomes into valuations, with the sector factoring significant regulatory relief, less restrictive capital requirements, and higher capital returns, the analyst tells investors in a research note. JPMorgan believes this limits upside with risk/rewards "skewing unfavorably as premium valuations may constrain returns and downside scenarios could be exacerbated should events fail to unfold as expected."
Richard Shane
JP Morgan
Hold
2024-10-07
Price Target
$36 → $38
Upside
+6.32%
